INCYTE CORPORATION Operating Income
INCYTE CORPORATION (INCY) reported Operating Income of $301.12 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-04-28
- INCYTE CORPORATION operating income (loss) for the quarter ending 2026-03-31 was $301.12M, a 46.77% increase year-over-year.
- INCYTE CORPORATION operating income (loss) for the quarter ending 2025-12-31 was $335.86M, a 11.39% increase year-over-year.
- INCYTE CORPORATION operating income (loss) for the quarter ending 2025-09-30 was $443.52M, a 203.60% increase year-over-year.
- INCYTE CORPORATION operating income (loss) for the quarter ending 2025-06-30 was $530.31M.
- INCYTE CORPORATION operating income (loss) for fiscal 2025 was $1.51B, a 2368.56% increase from fiscal 2024.
- INCYTE CORPORATION operating income (loss) for fiscal 2024 was $61.37M, a 90.11% decline from fiscal 2023.
- INCYTE CORPORATION operating income (loss) for fiscal 2023 was $620.52M, a 7.09% increase from fiscal 2022.
- INCYTE CORPORATION operating income (loss) for fiscal 2022 was $579.44M, a 1.08% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $301.12M 10-Q · filed 2026-04-28 | $636.98M derived: sum of 2 quarters · filed 2026-04-28 | $1.08B derived: sum of 3 quarters · filed 2026-04-28 | $1.61B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-12-31 | $335.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $779.38M derived: sum of 2 quarters · filed 2026-02-10 | $1.31B derived: sum of 3 quarters · filed 2026-02-10 | $1.51B 10-K · filed 2026-02-10 | ||||
| 2025-09-30 | $443.52M 10-Q · filed 2025-10-28 | $973.83M derived: sum of 2 quarters · filed 2025-10-28 | $1.18B 10-Q · filed 2025-10-28 | $1.48B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-06-30 | $530.31M 10-Q · filed 2025-07-29 | $735.48M 10-Q · filed 2025-07-29 | $1.04B derived: sum of 3 quarters · filed 2026-04-28 | $1.18B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-03-31 | $205.17M 10-Q · filed 2026-04-28 | $506.68M derived: sum of 2 quarters · filed 2026-04-28 | $652.77M derived: sum of 3 quarters · filed 2026-04-28 | $174.64M derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2024-12-31 | $301.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $447.60M derived: sum of 2 quarters · filed 2026-02-10 | -$30.53M derived: sum of 3 quarters · filed 2026-02-10 | $61.37M 10-K · filed 2026-02-10 | ||||
| 2024-09-30 | $146.09M 10-Q · filed 2025-10-28 | -$332.05M derived: sum of 2 quarters · filed 2025-10-28 | -$240.15M 10-Q · filed 2025-10-28 | -$52.88M derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2024-06-30 | -$478.13M 10-Q · filed 2025-07-29 | -$386.23M 10-Q · filed 2025-07-29 | -$198.96M derived: sum of 3 quarters · filed 2026-02-10 | $15.74M derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2024-03-31 | $91.90M 10-Q · filed 2025-04-29 | $279.17M derived: sum of 2 quarters · filed 2026-02-10 | $493.87M derived: sum of 3 quarters · filed 2026-02-10 | $687.65M derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2023-12-31 | $187.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $401.98M derived: sum of 2 quarters · filed 2026-02-10 | $595.75M derived: sum of 3 quarters · filed 2026-02-10 | $620.52M 10-K · filed 2026-02-10 | ||||
| 2023-09-30 | $214.71M 10-Q · filed 2024-10-29 | $408.49M derived: sum of 2 quarters · filed 2024-10-29 | $433.25M 10-Q · filed 2024-10-29 | $503.35M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-06-30 | $193.78M 10-Q · filed 2024-07-30 | $218.55M 10-Q · filed 2024-07-30 | $288.64M derived: sum of 3 quarters · filed 2025-02-10 | $427.02M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-03-31 | $24.77M 10-Q · filed 2024-04-30 | $94.86M derived: sum of 2 quarters · filed 2025-02-10 | $233.24M derived: sum of 3 quarters · filed 2025-02-10 | $487.67M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2022-12-31 | $70.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $208.47M derived: sum of 2 quarters · filed 2025-02-10 | $462.90M derived: sum of 3 quarters · filed 2025-02-10 | $579.44M 10-K · filed 2025-02-10 | ||||
| 2022-09-30 | $138.38M 10-Q · filed 2023-10-31 | $392.81M derived: sum of 2 quarters · filed 2023-10-31 | $509.35M 10-Q · filed 2023-10-31 | $620.08M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-06-30 | $254.43M 10-Q · filed 2023-08-01 | $370.97M 10-Q · filed 2023-08-01 | $481.70M derived: sum of 3 quarters · filed 2024-02-13 | $717.12M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-03-31 | $116.54M 10-Q · filed 2023-05-02 | $227.27M derived: sum of 2 quarters · filed 2024-02-13 | $462.68M derived: sum of 3 quarters · filed 2024-02-13 | $603.52M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2021-12-31 | $110.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $346.14M derived: sum of 2 quarters · filed 2024-02-13 | $486.98M derived: sum of 3 quarters · filed 2024-02-13 | $585.78M 10-K · filed 2024-02-13 | ||||
| 2021-09-30 | $235.41M 10-Q · filed 2022-11-01 | $376.25M derived: sum of 2 quarters · filed 2022-11-01 | $475.04M 10-Q · filed 2022-11-01 | $639.27M derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2021-06-30 | $140.84M 10-Q · filed 2022-08-02 | $239.63M 10-Q · filed 2022-08-02 | $403.86M derived: sum of 3 quarters · filed 2023-02-07 | $409.19M derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2021-03-31 | $98.80M 10-Q · filed 2022-05-03 | $263.03M derived: sum of 2 quarters · filed 2023-02-07 | $268.35M derived: sum of 3 quarters · filed 2023-02-07 | $499.13M derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2020-12-31 | $164.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $169.56M derived: sum of 2 quarters · filed 2023-02-07 | $400.33M derived: sum of 3 quarters · filed 2023-02-07 | -$263.68M 10-K · filed 2023-02-07 | ||||
| 2020-09-30 | $5.33M 10-Q · filed 2021-11-02 | $236.10M derived: sum of 2 quarters · filed 2021-11-02 | -$427.90M 10-Q · filed 2021-11-02 | -$332.90M derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2020-06-30 | $230.77M 10-Q · filed 2021-08-03 | -$433.23M 10-Q · filed 2021-08-03 | -$338.22M derived: sum of 3 quarters · filed 2022-02-08 | -$203.91M derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2020-03-31 | -$664.00M 10-Q · filed 2021-05-04 | -$569.00M derived: sum of 2 quarters · filed 2022-02-08 | -$434.68M derived: sum of 3 quarters · filed 2022-02-08 | -$336.07M derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2019-12-31 | $95.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $229.32M derived: sum of 2 quarters · filed 2022-02-08 | $327.94M derived: sum of 3 quarters · filed 2022-02-08 | $402.01M 10-K · filed 2022-02-08 | ||||
| 2019-09-30 | $134.32M 10-Q · filed 2020-11-05 | $232.93M derived: sum of 2 quarters · filed 2020-11-05 | $307.00M 10-Q · filed 2020-11-05 | $388.97M derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-06-30 | $98.61M 10-Q · filed 2020-08-04 | $172.68M 10-Q · filed 2020-08-04 | $254.66M derived: sum of 3 quarters · filed 2021-02-09 | $285.78M derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-03-31 | $74.07M 10-Q · filed 2020-05-05 | $156.04M derived: sum of 2 quarters · filed 2021-02-09 | $187.16M derived: sum of 3 quarters · filed 2021-02-09 | $270.40M derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2018-12-31 | $81.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $113.09M derived: sum of 2 quarters · filed 2021-02-09 | $196.33M derived: sum of 3 quarters · filed 2021-02-09 | $129.22M 10-K · filed 2021-02-09 | ||||
| 2018-09-30 | $31.12M 10-Q · filed 2019-10-29 | $114.36M derived: sum of 2 quarters · filed 2019-10-29 | $47.25M 10-Q · filed 2019-10-29 | -$85.17M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $83.24M 10-Q · filed 2019-07-30 | $16.13M 10-Q · filed 2019-07-30 | -$116.29M derived: sum of 3 quarters · filed 2020-02-13 | -$101.27M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | -$67.11M 10-Q · filed 2019-04-30 | -$199.53M derived: sum of 2 quarters · filed 2020-02-13 | -$184.51M derived: sum of 3 quarters · filed 2020-02-13 | -$177.25M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | -$132.42M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$117.40M derived: sum of 2 quarters · filed 2020-02-13 | -$110.14M derived: sum of 3 quarters · filed 2020-02-13 | -$243.39M 10-K · filed 2020-02-13 | -$243.73M 10-K · filed 2018-02-15 | |||
| 2017-09-30 | $15.02M 10-Q · filed 2018-10-30 | $14.96M 10-Q · filed 2017-10-31 | $22.28M derived: sum of 2 quarters · filed 2018-10-30 | -$110.97M 10-Q · filed 2018-10-30 | -$111.15M 10-Q · filed 2017-10-31 | -$68.89M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-06-30 | $7.26M 10-Q · filed 2018-07-31 | $7.20M 10-Q · filed 2017-08-01 | -$125.99M 10-Q · filed 2018-07-31 | -$126.10M 10-Q · filed 2017-08-01 | -$83.91M derived: sum of 3 quarters · filed 2019-02-14 | -$61.62M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-03-31 | -$133.25M 10-Q · filed 2018-05-01 | -$133.30M 10-Q · filed 2017-05-04 | -$91.17M derived: sum of 2 quarters · filed 2019-02-14 | -$68.88M derived: sum of 3 quarters · filed 2019-02-14 | -$24.29M derived: sum of 4 quarters · filed 2019-02-14 | |||
| 2016-12-31 | $42.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $64.37M derived: sum of 2 quarters · filed 2019-02-14 | $108.96M derived: sum of 3 quarters · filed 2019-02-14 | $145.00M 10-K · filed 2019-02-14 | ||||
| 2016-09-30 | $22.29M 10-Q · filed 2017-10-31 | $66.88M derived: sum of 2 quarters · filed 2017-10-31 | $102.92M 10-Q · filed 2017-10-31 | $168.00M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $44.59M 10-Q · filed 2017-08-01 | $80.63M 10-Q · filed 2017-08-01 | $145.71M derived: sum of 3 quarters · filed 2018-02-15 | $145.60M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $36.04M 10-Q · filed 2017-05-04 | $101.12M derived: sum of 2 quarters · filed 2018-02-15 | $101.02M derived: sum of 3 quarters · filed 2018-02-15 | $93.62M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $65.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $64.98M derived: sum of 2 quarters · filed 2018-02-15 | $57.58M derived: sum of 3 quarters · filed 2018-02-15 | $50.65M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | -$101.00K 10-Q · filed 2016-11-01 | -$7.50M derived: sum of 2 quarters · filed 2016-11-01 | -$14.43M 10-Q · filed 2016-11-01 | -$40.05M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-06-30 | -$7.39M 10-Q · filed 2016-08-09 | -$14.33M 10-Q · filed 2016-08-09 | -$39.95M derived: sum of 3 quarters · filed 2017-02-14 | $29.99M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-03-31 | -$6.93M 10-Q · filed 2016-05-09 | -$32.56M derived: sum of 2 quarters · filed 2017-02-14 | $37.38M derived: sum of 3 quarters · filed 2017-02-14 | $11.20M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2014-12-31 | -$25.62M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $44.32M derived: sum of 2 quarters · filed 2017-02-14 | $18.13M derived: sum of 3 quarters · filed 2017-02-14 | -$4.80M 10-K · filed 2017-02-14 | ||||
| 2014-09-30 | $69.94M 10-Q · filed 2015-11-03 | $43.76M derived: sum of 2 quarters · filed 2015-11-03 | $20.82M 10-Q · filed 2015-11-03 | $4.68M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-06-30 | -$26.19M 10-Q · filed 2015-08-04 | -$49.12M 10-Q · filed 2015-08-04 | -$65.26M derived: sum of 3 quarters · filed 2016-02-12 | -$78.45M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-03-31 | -$22.93M 10-Q · filed 2015-04-30 | -$39.08M derived: sum of 2 quarters · filed 2016-02-12 | -$52.26M derived: sum of 3 quarters · filed 2016-02-12 | -$34.94M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2013-12-31 | -$16.14M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | -$29.32M derived: sum of 2 quarters · filed 2016-02-12 | -$12.01M derived: sum of 3 quarters · filed 2016-02-12 | -$16.10M 10-K · filed 2016-02-12 | ||||
| 2013-09-30 | -$13.18M 10-Q · filed 2014-10-30 | $4.14M derived: sum of 2 quarters · filed 2014-10-30 | $39.00K 10-Q · filed 2014-10-30 | $30.29M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-06-30 | $17.32M 10-Q · filed 2014-07-31 | $13.22M 10-Q · filed 2014-07-31 | $43.48M derived: sum of 3 quarters · filed 2015-02-17 | $33.34M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-03-31 | -$4.10M 10-Q · filed 2014-05-01 | $26.16M derived: sum of 2 quarters · filed 2015-02-17 | $16.02M derived: sum of 3 quarters · filed 2015-02-17 | $31.24M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2012-12-31 | $30.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $20.12M derived: sum of 2 quarters · filed 2015-02-17 | $35.34M derived: sum of 3 quarters · filed 2015-02-17 | $1.15M 10-K · filed 2015-02-17 | ||||
| 2012-09-30 | -$10.14M 10-Q · filed 2013-10-31 | $5.08M derived: sum of 2 quarters · filed 2013-10-31 | -$29.11M 10-Q · filed 2013-10-31 | -$73.25M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-06-30 | $15.22M 10-Q · filed 2013-08-01 | -$18.97M 10-Q · filed 2013-08-01 | -$63.11M derived: sum of 3 quarters · filed 2014-02-21 | -$105.21M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-03-31 | -$34.19M 10-Q · filed 2013-05-02 | -$78.33M derived: sum of 2 quarters · filed 2014-02-21 | -$120.43M derived: sum of 3 quarters · filed 2014-02-21 | -$161.54M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2011-12-31 | -$44.14M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | -$86.24M derived: sum of 2 quarters · filed 2014-02-21 | -$127.36M derived: sum of 3 quarters · filed 2014-02-21 | -$143.18M 10-K · filed 2014-02-21 | ||||
| 2011-09-30 | -$42.10M 10-Q · filed 2012-11-01 | -$83.22M derived: sum of 2 quarters · filed 2012-11-01 | -$99.04M 10-Q · filed 2012-11-01 | -$56.73M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | -$41.11M 10-Q · filed 2012-08-03 | -$56.94M 10-Q · filed 2012-08-03 | -$14.63M derived: sum of 3 quarters · filed 2013-02-21 | -$36.68M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | -$15.82M 10-Q · filed 2012-04-26 | $26.49M derived: sum of 2 quarters · filed 2013-02-21 | $4.43M derived: sum of 3 quarters · filed 2013-02-21 | $18.05M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | $42.31M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $20.25M derived: sum of 2 quarters · filed 2013-02-21 | $33.88M derived: sum of 3 quarters · filed 2013-02-21 | $14.05M 10-K · filed 2013-02-21 | ||||
| 2010-09-30 | -$22.06M 10-Q · filed 2011-10-27 | -$8.43M derived: sum of 2 quarters · filed 2011-10-27 | -$28.26M 10-Q · filed 2011-10-27 | |||||
| 2010-06-30 | $13.62M 10-Q · filed 2011-07-28 | -$6.21M 10-Q · filed 2011-07-28 | ||||||
| 2010-03-31 | -$19.83M 10-Q · filed 2011-05-03 | |||||||
| 2009-12-31 | -$139.77M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |